128 results
8-K
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely by Regulation FD.
Item 9.01
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
STRATEGY & GOVERNANCE Conducted a revised global ESG materiality assessment Expanded ESG operating model to further align with company strategy
8-K
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
for the benefit of the parties thereto and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable
8-K
g1w8ksr 9nu
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
63cgefb3ze
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
4z5z583zg5 xydt1
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
mym5rmw ns
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
s5frxm
25 Jan 24
Third party tender offer statement
8:13am
8-K
b4pok1694
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
EX-99.1
u24mkt
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
wf0hlxjxxhp88
13 Nov 23
Other Events
4:19pm
8-K
icavuqwqioyvc2qmik6g
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
opzkk
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
ocqvi
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
i7naahdps00sipfdal
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
j3xjtny8y0db
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
SC TO-T
EX-99
maua56eq
17 Jun 22
Third party tender offer statement
4:42pm
SC TO-T
EX-99
lyc mjphk9yrnn
17 Jun 22
Third party tender offer statement
4:42pm